Cargando…
Mechanism of Ad5 Vaccine Immunity and Toxicity: Fiber Shaft Targeting of Dendritic Cells
Recombinant adenoviral (rAd) vectors elicit potent cellular and humoral immune responses and show promise as vaccines for HIV-1, Ebola virus, tuberculosis, malaria, and other infections. These vectors are now widely used and have been generally well tolerated in vaccine and gene therapy clinical tri...
Autores principales: | Cheng, Cheng, Gall, Jason G. D, Kong, Wing-pui, Sheets, Rebecca L, Gomez, Phillip L, King, C. Richter, Nabel, Gary J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803013/ https://www.ncbi.nlm.nih.gov/pubmed/17319743 http://dx.doi.org/10.1371/journal.ppat.0030025 |
Ejemplares similares
-
Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts
por: Sheets, Rebecca L., et al.
Publicado: (2006) -
Role of Fiber Shaft Length in Tumor Targeting with Ad5/3 Vectors
por: Richter, Maximilian, et al.
Publicado: (2022) -
Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination
por: Cheng, Cheng, et al.
Publicado: (2012) -
P17-27. Development of recombinant adenovirus 28 vectors for HIV vaccines
por: Ko, S, et al.
Publicado: (2009) -
Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination
por: Cheng, Cheng, et al.
Publicado: (2012)